聚合体膜工程具有主动准或可控制的透性,用于响应性药物输送
Anum Kayani1,2, Arsalan Raza1,2, Jiale Si1
1School of Chemistry, Engineering Research Center of Energy Storage Materials and Devices, Ministry of Education, Xi'an Jiaotong University, Xi'an 710049, Shaanxi, China.
Biomacromolecules
|October 23, 2023
概括
用作药物递送的纳米载体的聚合体通过表面功能化来增强有针对性的递送和刺激响应膜以控制释放,克服了以前的限制.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 聚合体作为纳米载体具有优势,包括稳定性,双重药物封装和可调节性质.
- 传统聚合体的局限性包括非特异性传递和不充分的膜透性.
- 最近的进展侧重于功能化聚合体,以提高向性和控制药物释放.
研究的目的:
- 审查聚合体膜的工程,以改善药物输送应用.
- 突出表面功能化策略,以实现主动准.
- 总结一下刺激响应膜的近期进展,以控制药物释放.
主要方法:
- 对药物输送中的聚合体功能化文献的综述.
- 分析用于主动准的表面改造技术.
- 检查刺激响应组件用于膜透性控制.
主要成果:
- 表面功能化使得针对特定疾病,细胞或器官的向传递成为可能.
- 纳入刺激反应元件允许控制药物释放动力学.
- 工程聚合物生物界面为先进的纳米医学提供了多功能平台.
结论:
- 聚合体膜工程对于克服药物输送的局限性至关重要.
- 表面功能化和响应刺激的设计是下一代聚合体的关键策略.
- 进一步的开发有望为有效的体内药物输送应用提供希望.
相关概念视频
Cellular Membranes and Drug Transport
603
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
603
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
566
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
566
Carrier-Mediated Transport
448
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
448
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
209
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
209
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
3.8K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
3.8K
Facilitated Diffusion
484
The plasma membrane, a critical structure in cellular biology, houses an array of transporters, or carrier proteins, interspersed within its lipid bilayer. These proteins play a crucial role in solute transport through facilitated diffusion, a form of passive diffusion that uses transporters to move the molecules across the membrane.
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
484


